"Essential Business IP and Regulatory Issues for Emerging Life Sciences Companies" RTA@Connect. In order to succeed, an emerging life sciences company team must craft and implement a comprehensive business plan, protect its valuable intellectual property, and navigate through the complex regulatory waters posed by the FDA approval process. Four experienced legal strategists who specialize in corporate structure and capital formation, I.P. protection, FDA law and health care reimbursement will offer valuable insights. See http://www.connect.kintera.org/rtaworkshops |